Healthy Skepticism Library item: 642
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Alliot LS.
Criticism of Servier re perindopril.
Lancet 1996 Mar 23; 347:(9004):832
Keywords:
*letter to the editor
Medical Lobby for Appropriate Marketing
MaLAM
Servier
quality of information
industry perspective
health and healthcare
Coversyl
perindopril
ATTITUDES REGARDING PROMOTION: INDUSTRY
INFLUENCE OF PROMOTION: HEALTH AND HEALTH CARE
Notes:
Contrary to the claims by the Medical Lobby for Appropriate Marketing, there is clinical evidence that perindopril has the ability to correct cardiovascular structural changes in hypertensive patients.
